EMBARGOED FOR RELEASE聽|聽August 21, 2012

Teva Pharmaceuticals Scholars awardees describe discoveries on cancer, hepatitis, drug delivery

Note to journalists: Please report that this research was presented at a meeting of the American Chemical 中国365bet中文官网.

PHILADELPHIA, Aug. 21, 2012 鈥� Current recipients of a prestigious award from the world鈥檚 largest scientific society will present results of their research here today, and new recipients of the Teva Pharmaceuticals Scholars Grants聽will be announced during a symposium at the 244th National Meeting & Exposition of the American Chemical 中国365bet中文官网 (ACS).

The presentations, from 1 p.m. to 5 p.m. in Room 203AB of the Pennsylvania Convention Center, feature new discoveries on anti-cancer drugs made from antibiotics, a potential new drug for hepatitis C and a new approach for delivering drugs to the body. ACS鈥� Board Standing Committee on Grants and Awards and the ACS Division of Organic Chemistry are co-sponsoring the symposium, which will include an intermission reception hosted by , which funds the scholars grants.

The Teva Pharmaceuticals Scholars Grants are $100,000, three-year awards given to researchers in the area of organic chemistry, with 鈥減otential or direct connections with medicinal chemistry, such that the successful results would be of practical benefit to the discovery of organic compounds useful as human medicines.鈥�

Presentations at this symposium will include:

  • Brian Stoltz, Ph.D., of the California Institute of Technology, 鈥淎 novel approach to antitumor antibiotics: Using the power of benzyne in synthesis.鈥�
  • Alexander Dieters, Ph.D., of North Carolina State University, 鈥淒iscovery and application of small molecule modifiers of microRNA function.鈥�
  • Xin Guo, Ph.D., of the University of the Pacific, 鈥淭rans-2-aminocyclohexanol-based lipids as pH-sensitive conformational switches in liposomes for drug delivery.鈥�

A new group of Teva Pharmaceuticals Scholars will be announced during the event.

###

The American Chemical 中国365bet中文官网 (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the transforming power of chemistry. Its mission is to advance scientific knowledge, empower a global community and champion scientific integrity, and its vision is a world built on science. The 中国365bet中文官网 is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical聽Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world鈥檚 scientific knowledge. ACS鈥� main offices are in Washington, D.C., and Columbus, Ohio.

Registered journalists can subscribe to the to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org.

Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.